BIOARRAY: A Start-Up Story Increasing Treatment Success Rates Through Personalized Medicine
You must register by April 15 for this event!
Wednesday, April 16, 2014
4:30 pm – 6:00 pm
Pfizer Inc. Groton, CT
Personalized medicine is what inspired Marcia Fournier to start her own company, BIOARRAY Therapeutics Inc. (BIOARRAY) a start-up biotech based in CT. BIOARRAY is developing diagnostic tests to match a breast cancer patient with the right drug the first time. BIOARRAY’s lead test has been shown to reduce ineffective treatments by over 50% in proof of concept studies. Marcia will talk about how the company is developing the technology from discovery to product development stage leveraging the study of cancer in reverse, and the experience of partners.
BIOARRAY is a recipient of Avon Foundation for Women and Connecticut Innovations funds. BIOARRAY was nominated the “Most Promising Life Science Product” by CT Technology Council and is a MassChallenge Accelerator Winner.
Marcia, a molecular biologist, came to the United States from Brazil about 15 years ago. Marcia is trained in genetics with 10+ years of experience in cancer research. She most recently held a position at GlaxoSmithKline, Oncology Center of Excellence for Drug Discovery. Marcia’s work as a doctoral fellow at the Dana-Farber Institute and postdoctoral fellow at UC Berkeley led to seminal publications on biomarker discovery.
— OTHER UPCOMING EVENTS —
4/29 4:00 pm – 6:00 pm
Yale & CURE BioHaven presents ‘New Antibiotics: From a Nobel Prize to a Pipeline – The story of Melinta.’ Yale Anlyan Center, 300 Cedar Street, New Haven more
5/12 5:00 pm – 6:30 pm
Bioscience Clubhouse presents ‘A Novel Cause-Effect Analysis Platform for Predicting Probability of R&D Program Success.’ CURE at The Grove, 760 Chapel Street, New Haven more